4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000007
CIK 0001534120other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:10 PM ET
Size
9.8 KB
Accession
0001929354-23-000007
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-05-05$2.88/sh+5,000$14,375→ 1,337,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-05-08$2.62/sh+5,000$13,108→ 1,342,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-05-04$2.79/sh+15,000$41,882→ 1,332,700 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.85, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.9, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.575 to $2.68, inclusive.
- [F5]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:10 PM ET
- Size
- 9.8 KB